VNDA News and Press, Vanda Pharmaceuticals Inc. From 04/05/24

2024-04-05 09:13:48 ET Summary Vanda Pharmaceuticals Inc. stock is down 17% since my July "hold" rating; the FDA approved Fanapt for bipolar I disorder, and stock jumped. The approval of Fanapt for bipolar disorder may not significantly contribute to Vanda's bottom line as there a...

2024-04-03 12:50:29 ET DENVER, Colo., Apr 03, 2024 ( 247marketnews.com )- MoBot’s, the 24/7MN Momentum Bot, recent alerts included Vanda Pharmaceuticals Inc. (NASDAQ: VNDA ), XTI Aerospace, Inc. (NASDAQ:XTIA), VivoPower International PLC (NASDAQ: VVPR ), CXApp Inc. (NASDA...

Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is one of today's top gainers. The company's shares have moved 37.98% on the day to $5.39. Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The c...

2024-04-03 10:00:34 ET More on Health Care Select Sector SPDR XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run Eli ...

2024-04-03 08:46:18 ET DENVER, Colo., Apr 03, 2024 ( 247marketnews.com )- Vanda Pharmaceuticals Inc. (NASDAQ: VNDA ) today announced that the U.S. Food and Drug Administration approved Fanapt ® (iloperidone), an atypical antipsychotic agent that has been used for the acute ...

2024-04-03 06:22:57 ET Vanda Pharmaceuticals ( NASDAQ: VNDA ) shares jumped 29% premarket on Wednesday after the U.S. Food and Drug Administration (FDA) cleared its Fanapt (iloperidone) tablets for the acute treatment of manic or mixed episodes associated with bipolar I disorder...

2024-04-03 05:15:26 ET More on related stocks: Dave & Buster's Q4 Earnings: Ready To Move Higher, 4x EBITDA Dave & Buster's Entertainment, Inc. (PLAY) Q4 2023 Earnings Call Transcript Intel Corporation (INTC) New Segment Reporting Webinar (Transcript) ...

Vanda Pharmaceuticals' Fanapt® (iloperidone) Receives U.S. FDA Approval for the Acute Treatment of Bipolar I Disorder PR Newswire Fanapt ® Treatment is Now Available to Adult Patients for the Acute Treatment of Manic or Mixed Episodes Associated with Bipolar ...

2024-04-02 16:43:27 ET Gainers: Sight Sciences ( SGHT ) +19% . Zapata Computing Holdings  ( ZPTA ) +9% . Cal-Maine Foods ( CALM ) +6% . Vanda Pharmaceuticals  ( VNDA ) +5% . iHeartMedia ( IHRT ) +5% . Losers: Ac...

2024-03-06 08:24:28 ET More on Pre-market losers & stocks. Datasea jumps 23% as subsidiary enters a potential $30M sale agreement Seeking Alpha’s Quant Rating on BeyondSpring Historical earnings data for BeyondSpring Financial information for Beyon...